Androgen receptor inhibition has also been hypothesized to be a more effective treatment for prostate cancer patients with HRD because of the role that androgen receptor signaling plays in the regulation of DNA repair. The gene discussed is AR; the disease is hypoparathyroidism-retardation-dysmorphism syndrome.